Although coding for long-term medications is not a difficult process, it often involves communicating with other physicians or specialists to obtain accurate information. While this clinical example focuses on Plaquenil, the concept works for any long-term medication. Teva-chloroquine effets secondaires How long does it take plaquenil to affect bones Is hydroxychloroquine sulfate an immunosuppressive drug M32.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM M32.9 became effective on October 1, 2019. This is the American ICD-10-CM version of M32.9 - other international versions of ICD-10 M32.9 may differ. Question How should we code exams for patients on high-risk medications in ICD-10? Answer When the doctor finds no pathology, code the systemic disease, such as L93.0 Lupus or M06.09 Rheumatoid arthritis. ICD-10's Z79.899 Other long term current drug therapy should be linked to any tests performed. Systemic lupus erythematosus lupus is a chronic autoimmune disease that causes inflammation in various parts of the body. This blog provides some documentation guidelines and the ICD-10 codes used for reporting this condition. Because Plaquenil does not have its own specific category, clinicians should use Z79.899—Other Long Term (Current) Drug Therapy. The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Plaquenil icd 10 Coding for Plaquenil Toxicity Observation - CPT®, ICD-10, HCPCS, Coding exams for patients on high-risk medications - American. Chloroquine phosphate medicineChloroquine phosphate 500 mg side effectsPlaquenil good reviewsWhat is a plaquenil eye exam High Risk Factors Asian ethnicity Tamoxifen use Macular disease AMD, ERM, etc. Kidney renal or Liver hepatic disease Plaquenil hydroxychloroquine Screening, ICD-10 Z79.889. Reporting Systemic Lupus Erythematosus with the Correct ICD-10 Codes. Hydroxychloroquine ICD-10-CM Drugs Index. Our office has been including a second diagnosis for the disease related to Plaquenil use. We aren't seeing denials using that method but from a coding standpoint I don't know if that is a 'more correct' coding or if we are just billing different insurances and getting different responses regardless of our using a second dx code. Answer When billing Plaquenil examinations, or any other high risk medication exams, it is appropriate to bill the systemic disease or any ocular manifestations as the primary diagnosis since many payers may not reimburse for the high-risk medication diagnosis as a stand-alone diagnosis. Testing services performed should have the high-risk. Valid for Submission. H35.389 is a billable code used to specify a medical diagnosis of toxic maculopathy, unspecified eye. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code H35.389 might also be used to specify conditions or terms like toxic maculopathy.